197 related articles for article (PubMed ID: 7689283)
1. Principal neutralizing domain of HIV-1 is highly immunogenic when expressed on the surface of hepatitis B core particles.
von Brunn A; Brand M; Reichhuber C; Morys-Wortmann C; Deinhardt F; Schödel F
Vaccine; 1993; 11(8):817-24. PubMed ID: 7689283
[TBL] [Abstract][Full Text] [Related]
2. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
Kang CY; Luo L; Wainberg MA; Li Y
Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338
[TBL] [Abstract][Full Text] [Related]
3. The position of heterologous epitopes inserted in hepatitis B virus core particles determines their immunogenicity.
Schödel F; Moriarty AM; Peterson DL; Zheng JA; Hughes JL; Will H; Leturcq DJ; McGee JS; Milich DR
J Virol; 1992 Jan; 66(1):106-14. PubMed ID: 1370083
[TBL] [Abstract][Full Text] [Related]
4. A virulent Salmonella expressing hybrid hepatitis B virus core/pre-S genes for oral vaccination.
Schödel F; Peterson D; Hughes J; Milich DR
Vaccine; 1993; 11(2):143-8. PubMed ID: 7679864
[TBL] [Abstract][Full Text] [Related]
5. Hybrid hepatitis B virus core antigen as a vaccine carrier moiety: I. presentation of foreign epitopes.
Schödel F; Peterson D; Hughes J; Wirtz R; Milich D
J Biotechnol; 1996 Jan; 44(1-3):91-6. PubMed ID: 8717391
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B virus core and e antigen: immune recognition and use as a vaccine carrier moiety.
Schödel F; Peterson D; Milich D
Intervirology; 1996; 39(1-2):104-10. PubMed ID: 8957676
[TBL] [Abstract][Full Text] [Related]
7. Characterization of an internal permissive site in the cholera toxin B-subunit and insertion of epitopes from human immunodeficiency virus-1, hepatitis B virus and enterotoxigenic Escherichia coli.
Bckström M; Holmgren J; Schödel F; Lebens M
Gene; 1995 Nov; 165(2):163-71. PubMed ID: 8522171
[TBL] [Abstract][Full Text] [Related]
8. The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAI on the immunogenicity of the envelope protein.
Peet NM; McKeating JA; de Souza JB; Roitt IM; Delves PJ; Lund T
Virology; 1998 Nov; 251(1):59-70. PubMed ID: 9813203
[TBL] [Abstract][Full Text] [Related]
9. Expression and characterization of genetically engineered human immunodeficiency virus-like particles containing modified envelope glycoproteins: implications for development of a cross-protective AIDS vaccine.
Rovinski B; Haynes JR; Cao SX; James O; Sia C; Zolla-Pazner S; Matthews TJ; Klein MH
J Virol; 1992 Jul; 66(7):4003-12. PubMed ID: 1602531
[TBL] [Abstract][Full Text] [Related]
10. Antigenicity and predefined specificities of the multi-epitope vaccine in candidate consisting of neutralizing epitope and mutated epitopes suggested a new way against HIV-1 mutation.
Tian H; Xiao Y; Qin L; Chen YH
Immunobiology; 2001 Dec; 204(4):434-41. PubMed ID: 11776398
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of hybrid DNA vaccines expressing hepatitis B core particles carrying human and simian immunodeficiency virus epitopes in mice and rhesus macaques.
Fuller DH; Shipley T; Allen TM; Fuller JT; Wu MS; Horton H; Wilson N; Widera G; Watkins DI
Virology; 2007 Aug; 364(2):245-55. PubMed ID: 17428516
[TBL] [Abstract][Full Text] [Related]
12. Relationship between antigenicity and immunogenicity of chimeric hepatitis B virus core particles carrying HIV type 1 epitopes.
Grene E; Mezule G; Borisova G; Pumpens P; Bentwich Z; Arnon R
AIDS Res Hum Retroviruses; 1997 Jan; 13(1):41-51. PubMed ID: 8989426
[TBL] [Abstract][Full Text] [Related]
13. Development of recombinant Salmonellae expressing hybrid hepatitis B virus core particles as candidate oral vaccines.
Schödel F; Kelly SM; Peterson D; Milich D; Hughes J; Tinge S; Wirtz R; Curtiss R
Dev Biol Stand; 1994; 82():151-8. PubMed ID: 7958469
[TBL] [Abstract][Full Text] [Related]
14. Design of immunogens that present the crown of the HIV-1 V3 loop in a conformation competent to generate 447-52D-like antibodies.
Chakraborty K; Durani V; Miranda ER; Citron M; Liang X; Schleif W; Joyce JG; Varadarajan R
Biochem J; 2006 Nov; 399(3):483-91. PubMed ID: 16827663
[TBL] [Abstract][Full Text] [Related]
15. Improved humoral and cellular immune responses against the gp120 V3 loop of HIV-1 following genetic immunization with a chimeric DNA vaccine encoding the V3 inserted into the hepatitis B surface antigen.
Fomsgaard A; Nielsen HV; Bryder K; Nielsen C; Machuca R; Bruun L; Hansen J; Buus S
Scand J Immunol; 1998 Apr; 47(4):289-95. PubMed ID: 9600309
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of recombinant core particles of hepatitis B virus containing epitopes of human immunodeficiency virus 1 core antigen.
Ulrich R; Borisova GP; Gren E; Berzin I; Pumpen P; Eckert R; Ose V; Siakkou H; Gren EJ; von Baehr R
Arch Virol; 1992; 126(1-4):321-8. PubMed ID: 1381912
[TBL] [Abstract][Full Text] [Related]
17. Induction of antibodies to the human immunodeficiency virus type 1 by immunization of baboons with immunoglobulin molecules carrying the principal neutralizing determinant of the envelope protein.
Zaghouani H; Anderson SA; Sperber KE; Daian C; Kennedy RC; Mayer L; Bona CA
Proc Natl Acad Sci U S A; 1995 Jan; 92(2):631-5. PubMed ID: 7831341
[TBL] [Abstract][Full Text] [Related]
18. Polyhistidine-tagged hepatitis B core particles as carriers of HIV-1/gp120 epitopes of different HIV-1 subtypes.
Wizemann H; Weiland F; Pfaff E; von Brunn A
Biol Chem; 2000 Mar; 381(3):231-43. PubMed ID: 10782994
[TBL] [Abstract][Full Text] [Related]
19. Hemagglutinating virus of Japan protein is efficient for induction of CD4+ T-cell response by a hepatitis B core particle-based HIV vaccine.
Takeda S; Shiosaki K; Kaneda Y; Nakasatomi T; Yoshizaki H; Someya K; Konno Y; Eda Y; Kino Y; Yamamoto N; Honda M
Clin Immunol; 2004 Jul; 112(1):92-105. PubMed ID: 15207786
[TBL] [Abstract][Full Text] [Related]
20. Cross-clade neutralizing antibodies against HIV-1 induced in rabbits by focusing the immune response on a neutralizing epitope.
Zolla-Pazner S; Cohen S; Pinter A; Krachmarov C; Wrin T; Wang S; Lu S
Virology; 2009 Sep; 392(1):82-93. PubMed ID: 19632700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
